[PETDAG] QoQ Quarter Result on 30-Sep-2012 [#3]

Stock
[PETDAG] PETRONAS DAGANGAN BHD
Announcement Date
29-Nov-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Sep-2012 [#3]
Profit Trend
QoQ- 41.72%
YoY- 8.38%
Quarter Report
Latest QR
Upcoming QR
PETDAG's Result
PETDAG's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 CAGR
Revenue 7,924,901 7,618,972 7,688,001 7,489,941 7,484,266 6,852,755 6,852,755 10.20%
PBT 273,041 326,969 250,756 340,494 234,237 339,686 339,686 -13.58%
Tax -74,940 -87,597 -72,970 -95,908 -61,223 -91,802 -91,802 -12.68%
NP 198,101 239,372 177,786 244,586 173,014 247,884 247,884 -13.91%
-
NP to SH 197,127 237,097 176,498 242,811 171,326 246,211 246,211 -13.81%
-
Tax Rate 27.45% 26.79% 29.10% 28.17% 26.14% 27.03% 27.03% -
Total Cost 7,726,800 7,379,600 7,510,215 7,245,355 7,311,252 6,604,871 6,604,871 11.05%
-
Net Worth 4,848,055 5,046,746 4,808,317 4,808,317 4,957,335 0 4,917,597 -0.94%
Dividend
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 CAGR
Div 173,854 173,854 173,854 173,854 173,854 173,854 173,854 0.00%
Div Payout % 88.19% 73.33% 98.50% 71.60% 101.48% 70.61% 70.61% -
Equity
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 CAGR
Net Worth 4,848,055 5,046,746 4,808,317 4,808,317 4,957,335 0 4,917,597 -0.94%
NOSH 993,454 993,454 993,454 993,454 993,454 993,454 993,454 0.00%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 CAGR
NP Margin 2.50% 3.14% 2.31% 3.27% 2.31% 3.62% 3.62% -
ROE 4.07% 4.70% 3.67% 5.05% 3.46% 0.00% 5.01% -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 CAGR
RPS 797.71 766.92 773.87 753.93 753.36 689.79 689.79 10.20%
EPS 19.80 23.90 17.80 24.40 17.30 24.80 24.80 -13.97%
DPS 17.50 17.50 17.50 17.50 17.50 17.50 17.50 0.00%
NAPS 4.88 5.08 4.84 4.84 4.99 0.00 4.95 -0.94%
Adjusted Per Share Value based on latest NOSH - 993,454
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 CAGR
RPS 796.90 766.14 773.08 753.16 752.59 689.09 689.09 10.20%
EPS 19.82 23.84 17.75 24.42 17.23 24.76 24.76 -13.82%
DPS 17.48 17.48 17.48 17.48 17.48 17.48 17.48 0.00%
NAPS 4.875 5.0748 4.8351 4.8351 4.9849 0.00 4.945 -0.94%
Price Multiplier on Financial Quarter End Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 CAGR
Date 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 -
Price 25.30 23.10 23.50 22.50 21.10 18.94 17.80 -
P/RPS 3.17 3.01 3.04 2.98 2.80 2.75 2.58 14.75%
P/EPS 127.50 96.79 132.27 92.06 122.35 76.42 71.82 46.76%
EY 0.78 1.03 0.76 1.09 0.82 1.31 1.39 -32.03%
DY 0.69 0.76 0.74 0.78 0.83 0.92 0.98 -20.90%
P/NAPS 5.18 4.55 4.86 4.65 4.23 0.00 3.60 27.53%
Price Multiplier on Announcement Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 01/01/12 CAGR
Date 21/08/13 23/05/13 06/03/13 29/11/12 16/08/12 - 21/05/12 -
Price 27.70 25.24 23.50 22.70 22.90 0.00 19.48 -
P/RPS 3.47 3.29 3.04 3.01 3.04 0.00 2.82 14.87%
P/EPS 139.60 105.76 132.27 92.88 132.79 0.00 78.60 46.81%
EY 0.72 0.95 0.76 1.08 0.75 0.00 1.27 -31.57%
DY 0.63 0.69 0.74 0.77 0.76 0.00 0.90 -21.21%
P/NAPS 5.68 4.97 4.86 4.69 4.59 0.00 3.94 27.70%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment